undamentalytics Newsletter
Sign in

Trevi Therapeutics, Inc. insider trading

Every open-market purchase and sale by Trevi Therapeutics, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

Insider purchases, 5 years $0 0 trades by 0 insiders Insider sales, 5 years $594,218 1 trade by 1 insider

No insider has bought shares on the open market in five years.

Insider purchase Insider sale Marker size reflects trade value. Weekly closes adjusted for splits; may be delayed.
DateInsiderTrade SharesPriceValue 1M after 3M after 6M after

From insiders' Form 4 filings with the SEC: open-market purchases and sales only (awards, option exercises and shares withheld for tax are excluded), combined to one line per insider per day. "Plan" marks trades the filing says were made under a pre-set Rule 10b5-1 trading plan, which are scheduled in advance. Price changes run from the close on the trade date; hover a figure for the change relative to the S&P 500. Past moves don't predict future ones.

Does following Trevi Therapeutics, Inc.’s insiders pay?

From April 13, 2022 to March 26, 2025, 8 insiders reported 2 open-market purchases and 14 sales not made under a pre-set plan in Trevi Therapeutics, Inc. After sales, the shares moved +60.5% against the index over 12 months (a negative figure means selling was the right call).

InsiderRolePurchases12 months after their purchasesBeat the S&P 500Sales12 months after their salesLatest report
Good Jennifer L President & CEO 0 — — 5 +62.3% (1) March 25, 2025
Sciascia Thomas Chief Scientific Officer 0 — — 4 +58.8% (1) March 26, 2025
Winkelried Jon Other 0 — — 2 — July 6, 2022
Baskett Forest and related entities 10% owner 1 — — 0 — April 13, 2022
Coulter James G 10% owner 0 — — 1 — May 2, 2022
Delfini Lisa Chief Financial Officer 0 — — 1 — May 24, 2024
Meeker David P Director 0 — — 1 — August 29, 2024
Sandell Scott D and related entities 10% owner 1 — — 0 — April 13, 2022

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

← Back to Trevi Therapeutics, Inc. · Funds · Politicians